Abstract
Background: Reliable and precise classification methods for tumor types have started to see wide deployment, in particular in the area of cancer diagnosis and personalized cancer drug design. The traditional Sparse Representation-based Classification (SRC) method can achieve high accuracy for tumor classification but also suffer from inefficiency when handling noisy datasets. To resist such disadvantage, some researchers proposed collaborative Representation–based Classification (CRC) method, which is more efficient and less complex.
Method: In this paper, we design a novel Kernelized Convex Hull Collaborative Representation and Classification (KCHCRC) approach to further improve it. Though modeling the testing sample as a special convex hull with a single element, the convex hull can collaboratively be represented over the whole training samples. When the represented coefficients are fixed, we can calculate the distance between the testing sample and training samples with identical type for each category. To demonstrate the performance of our approach, we compare with the prior state-of-the-art tumor classification methods on various 11 tumor gene expression datasets.
Result: The experimental results show that our approach is efficacy and efficiency.
Keywords: Tumor classification, Sparse Representation–based Classification (SRC), Collaborative Representation–based Classification (CRC), SVM, convex hull, gene expression.
Graphical Abstract
Current Proteomics
Title:Kernelized Convex Hull based Collaborative Representation for Tumor Classification
Volume: 15 Issue: 5
Author(s): Xia Chen, Haowen Chen*, Dan Cao and Bo Li
Affiliation:
- College of Information Science and Engineering, Hunan University, Changsha,China
Keywords: Tumor classification, Sparse Representation–based Classification (SRC), Collaborative Representation–based Classification (CRC), SVM, convex hull, gene expression.
Abstract: Background: Reliable and precise classification methods for tumor types have started to see wide deployment, in particular in the area of cancer diagnosis and personalized cancer drug design. The traditional Sparse Representation-based Classification (SRC) method can achieve high accuracy for tumor classification but also suffer from inefficiency when handling noisy datasets. To resist such disadvantage, some researchers proposed collaborative Representation–based Classification (CRC) method, which is more efficient and less complex.
Method: In this paper, we design a novel Kernelized Convex Hull Collaborative Representation and Classification (KCHCRC) approach to further improve it. Though modeling the testing sample as a special convex hull with a single element, the convex hull can collaboratively be represented over the whole training samples. When the represented coefficients are fixed, we can calculate the distance between the testing sample and training samples with identical type for each category. To demonstrate the performance of our approach, we compare with the prior state-of-the-art tumor classification methods on various 11 tumor gene expression datasets.
Result: The experimental results show that our approach is efficacy and efficiency.
Export Options
About this article
Cite this article as:
Chen Xia, Chen Haowen *, Cao Dan and Li Bo , Kernelized Convex Hull based Collaborative Representation for Tumor Classification, Current Proteomics 2018; 15 (5) . https://dx.doi.org/10.2174/1570164615666180315105458
DOI https://dx.doi.org/10.2174/1570164615666180315105458 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases
Current Signal Transduction Therapy Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy Current Status of Clinical Trials for Glioblastoma
Reviews on Recent Clinical Trials Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts
Current Cancer Drug Targets Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
Recent Patents on Anti-Cancer Drug Discovery MicroRNA Dysregulation in Gastric Cancer
Current Pharmaceutical Design Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms
Mini-Reviews in Medicinal Chemistry Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype
Current Molecular Medicine Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design Recent Progress in Polynuclear Ruthenium Complex-Based DNA Binders/Structural Probes and Anticancer Agents
Current Medicinal Chemistry The Molecular Basis of Herpesviruses as Oncolytic Agents
Current Pharmaceutical Biotechnology Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery MicroRNA and Cancer: Tiny Molecules with Major Implications
Current Genomics Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry Anthraquinones: Analytical Techniques as a Novel Tool to Investigate on the Triggering of Biological Targets
Current Drug Targets Imaging Tumor Metastases with Molecular Probes
Current Pharmaceutical Design Oncolytic Virotherapy for Breast Cancer Treatment
Current Gene Therapy The 18 kDa Mitochondrial Translocator Protein (TSPO) Prevents Accumulation of Protoporphyrin IX. Involvement of Reactive Oxygen Species (ROS)
Current Molecular Medicine